The startup develops a platform that integrates de-siloed health data from multiple sources to generate actionable insights for patient care. By ensuring compliance with GDPR, the solution provides healthcare professionals with tailored information on therapies and their real-world effects, enhancing treatment outcomes.
Funding
$44.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pharmaceutical companies often struggle with inefficient cross-functional team operations, inflexible strategies that fail to adapt to patient and healthcare professional needs, and undercapitalization due to overlooking real-world evidence in brand decisions. This leads to missed opportunities for growth and suboptimal brand performance.
Solution
Temedica provides a technology and AI-enabled solution and service for the pharmaceutical industry, empowering companies to achieve exceptional brand performance through holistic strategies and tactical execution. By de-siloing and combining anonymized health data, Temedica provides a 360-degree understanding of patients and their surrounding markets. The platform combines real-world insights, configurable AI-powered solutions, and in-house medical expertise to transform commercial hurdles into growth opportunities. Temedica's solutions enable pharma brands to thrive with data-driven insights and AI-powered analytics, turning raw data into ROI-driven success.
Target Audience
Temedica partners with pharmaceutical commercial functions across medical, marketing, sales, patient engagement, and business intelligence to remove barriers that keep brands from realizing their full potential.
Features
- Permea Insight Hub: Tailors real-world insights by role, brand, and lifecycle stage for faster, smarter brand decisions.
- Permea Disease Navigator: Identifies high-value regions, tracks diagnostic journeys, and maps critical care gaps with robust disease prevalence data.
- Permea Commercial Compass: Provides patient-level prescription data, arriving 15 days after the end of the month, to monitor prescription ramp-ups and adapt before competitors.
- Patient Companion: A digital guide to boost patient activation and adherence, capturing real-time insights and driving measurable ROI.
- Real-time data capture from medically validated questionnaires, encompassing over 10,000 parameters.
- Medical Publication services to enhance brand credibility with peer-reviewed evidence.
- Advanced dashboards transform data into strategic assets, providing actionable intelligence.